MITODX (Mitotane) 500mg 100 Tablets | BigBear Laos Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

مشاركة
Product description

Generic Information: MITODX (Mitotane) — BigBear Laos Generic

MITODX is the mitotane product of BigBear Pharmaceutical (Lao) Co., Ltd., a Vientiane manufacturer specializing in oncology, hematology, dermatology and rare-disease medicines. It carries Lao registration number 08L1004/23, and in 2024 BigBear achieved a milestone for the Lao pharmaceutical industry when MITODX became the country's first oncology and orphan drug ever exported to an ASEAN economy, shipping to Malaysia — a signal of how seriously the product is made and documented. Each bottle holds 100 tablets of 500 mg mitotane, with a 36-month shelf life.

What Is MITODX (Mitotane) Used For?

MITODX treats inoperable, functional or nonfunctional adrenocortical carcinoma, and is also used for adrenocortical hyperplasia and the cortisol excess of hormone-producing tumors — the same broad indications international practice recognizes for mitotane. For patients facing ACC, one of the rarest and most aggressive endocrine cancers, a documented generic is often the only financially sustainable route to continuous therapy, which is precisely why BigBear's product has found demand across Southeast Asia and beyond.

How Does MITODX (Mitotane) Work?

The active ingredient is mitotane, an adrenal cytotoxic agent. It inhibits cholesterol side-chain cleavage (CYP11A1), 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) to shut down steroid production, while its direct, selective toxicity — through mitochondrial disruption and SOAT1 inhibition — destroys adrenocortical cells and can induce lasting adrenal atrophy. The drug should be taken with fat-containing food (milk, chocolate, oil) because fat improves its absorption, a practical detail that matters for a lipophilic molecule.

Indications of MITODX (Laos)

The Lao indication covers inoperable functional and nonfunctional adrenocortical carcinoma, adrenocortical hyperplasia and cortisol excess from tumors. Clinical response in ACC is well documented — objective response rates of roughly 34% to 61%, with a median response duration of six to seven months — and for functional tumors the drug also relieves the hypercortisolism symptoms and can extend survival. MITODX is an adult therapy; pediatric safety has not been established.

Dosage and Administration

Dosing is individualized. A common starting point is 6–15 mg per kilogram per day in three or four divided doses, escalating to the maximum tolerated level — typically 2–16 g daily, with 8–10 g per day a frequent maintenance range. The guiding target is a plasma mitotane level of 14–20 mg/L. Tablets are swallowed whole with water and fat-containing food, never crushed or chewed. After a clinical response, the dose is often reduced to 2–4 g daily in four-to-eight-week cycles, and if three months at maximum tolerated dose brings no response, treatment is usually stopped. Supervision by an experienced physician is essential throughout.

Side Effects of MITODX

Gastrointestinal reactions are the most frequent (around 79% overall — anorexia, nausea, vomiting, diarrhea), followed by neuromuscular effects in about 49% (central nervous system depression, dizziness, tremor, fatigue). Skin reactions, eye toxicity (blurred vision, diplopia, lens opacity, retinopathy), and urogenital effects (hematuria, proteinuria, hemorrhagic cystitis) are less common but documented. The serious risks mirror the class: adrenal insufficiency and adrenal crisis — the boxed warning — plus hepatotoxicity, hematologic toxicity and fetal harm. Nonhormonal contraception is required, and breastfeeding is not recommended while the drug is detectable.

Storage Instructions

Store at 20–25°C, with short transport excursions allowed between 15°C and 30°C, sealed and protected from light. Keep out of children's reach. Unused cytotoxic tablets should be returned to a pharmacy for disposal, never put in household waste or drains.

Why Choose MITODX from GLT?

MITODX pairs a documented Lao registration (08L1004/23) with the only maker in Laos to have exported an oncology orphan drug across ASEAN borders — evidence of manufacturing and export discipline that matters when you are choosing a generic for a life-threatening rare cancer. GLT verifies every order: sealed bottles, batch documentation, pre-shipment photographs of the actual stock, and a direct human line on WhatsApp +86 15234153837 or [email protected]. We quote MITODX alongside Mytanne, LuciMito and the originator Lysodren presentations so the comparison is transparent.

How to Order MITODX (Mitotane)

Message WhatsApp +86 15234153837 or email [email protected] with your required quantity. GLT returns a formal quotation with shipping and payment options, usually within one working day, and dispatches sealed stock with export documentation on confirmation. Continuous-therapy schedules can be arranged so there is never a break in supply.

FAQ

What is MITODX's registration number? Lao registration 08L1004/23, issued by the Lao PDR authority and shown on the packaging.

How many tablets per bottle? 100 tablets of 500 mg, with a 36-month shelf life.

Why does food matter with mitotane? Fat in the meal improves absorption of this lipophilic drug, so MITODX is taken with fat-containing food such as milk, chocolate or oil.

What response can ACC patients expect? Clinical data report objective response rates around 34–61% and median response duration of six to seven months; the drug also controls hormone-related symptoms in functional tumors.

Is MITODX the same as Lysodren? Same active ingredient and strength (500 mg); MITODX is BigBear's Lao generic, bioequivalent in intent, with its own registration and packaging.

Related Oncology Products

SPINRAZA (نوسينرسن) 12 ملغ/5 مل | الشراء من الصين | علاج الضمور العضلي الشوكي | GLT

أول أوليغونوكليوتيد مضاد للمعنى من فئته من Biogen لعلاج الضمور العضلي الشوكي، معتمد من NMPA...

باريسينت (باريسيتينيب) 2ملغ | مثبط JAK1/JAK2 جنيس | إنسبتا للأدوية المحدودة | GLT

باريسيتينيب جنيس (مثبط JAK1/JAK2) من إنسبتا للأدوية المحدودة (بنغلاديش) — بديل ميسور التكلفة عن أولوميانت...

إلترومبوباغ (Promacta) أقراص 25/50 ملغ | ناهض TPO-R أصلي أمريكي | GLT

Promacta الأصلي من Novartis (إلترومبوباغ) 25 ملغ و50 ملغ، 30 قرصًا

بالوتيني (باريسيتينيب) 4ملغ | مثبط JAK1/JAK2 جنيس | ترانس كونتيننتال لايف ساينس آند فارماسيوتيكالز (TLPH) | GLT

باريسيتينيب جنيس (مثبط JAK1/JAK2) من ترانس كونتيننتال لايف ساينس آند فارماسيوتيكالز (TLPH) (لاوس) — بديل...

أفاتودكس (أفاترومبوباغ) 20ملغ*30 قرصاً | بيغبير للأدوية (لاوس) | GLT

أفاتودكس — أفاترومبوباغ 20ملغ من بيغبير للأدوية (لاوس) المحدودة، رقم تسجيل لاوس 06L0985/23، زجاجة من...

تيكسيبا (تيرزيباتيد) 20ملغ/2مل و30ملغ/2مل قلم متعدد الجرعات | دراغ إنترناشيونال | GLT

تيكسيبا — قلم متعدد الجرعات من تيرزيباتيد دراغ إنترناشيونال المحدودة (DIL)، بجرعتين رسميتين (تيكسيبا-5 =...

KangQuXin 康曲欣 (أفاترومبوباغ) 20 ملغ × 10 أقراص | Beijing Continent (Gyre) | GLT

KangQuXin — أفاترومبوباغ من Beijing Continent Pharmaceutical (Gyre Therapeutics، ناسداك: GYRE)، الصين

لوسيافات (أفاترومبوباغ) 20ملغ*28 قرصاً | لوسيوس للأدوية (لاوس) | GLT

لوسيافات — أقراص أفاترومبوباغ 20ملغ (ماليات 23.6ملغ) مطلية بغشاء من لوسيوس للأدوية (لاوس) المحدودة، فيينتيان.